Zhang Lab

National University of Singapore

Home Research COVID-19 Services Publications People Teaching Job Opening News Forum Lab Only

Online Services

●I-TASSER ●I-TASSER-MTD ●C-I-TASSER ●CR-I-TASSER ●QUARK ●C-QUARK ●LOMETS ●MUSTER ●CEthreader ●SEGMER ●DeepFold ●DeepFoldRNA ●FoldDesign ●COFACTOR ●COACH ●MetaGO ●TripletGO ●IonCom ●FG-MD ●ModRefiner ●REMO ●DEMO ●DEMO-EM ●SPRING ●COTH ●Threpp ●PEPPI ●BSpred ●ANGLOR ●EDock ●BSP-SLIM ●SAXSTER ●FUpred ●ThreaDom ●ThreaDomEx ●EvoDesign ●BindProf ●BindProfX ●SSIPe ●GPCR-I-TASSER ●MAGELLAN ●ResQ ●STRUM ●DAMpred

●TM-score ●TM-align ●US-align ●MM-align ●RNA-align ●NW-align ●LS-align ●EDTSurf ●MVP ●MVP-Fit ●SPICKER ●HAAD ●PSSpred ●3DRobot ●MR-REX ●I-TASSER-MR ●SVMSEQ ●NeBcon ●ResPRE ●TripletRes ●DeepPotential ●WDL-RF ●ATPbind ●DockRMSD ●DeepMSA ●FASPR ●EM-Refiner ●GPU-I-TASSER

●BioLiP ●E. coli ●GLASS ●GPCR-HGmod ●GPCR-RD ●GPCR-EXP ●Tara-3D ●TM-fold ●DECOYS ●POTENTIAL ●RW/RWplus ●EvoEF ●HPSF ●THE-DB ●ADDRESS ●Alpaca-Antibody ●CASP7 ●CASP8 ●CASP9 ●CASP10 ●CASP11 ●CASP12 ●CASP13 ●CASP14

GLASS

You can:

Go to the GPCR, ligand, or experimental data tables.
Go to the experimental data table for text mining information in PubMed ID column.
Go to the GPCR page and check other ligands which interact with it.
Go to the ligand page and check other GPCRs which it interacts with.
Go back to previous page.

GPCR

Name	5-hydroxytryptamine receptor 1B
Species	Homo sapiens (Human)
Gene	HTR1B
Synonym	5-HT1B receptor 5-HT-1B 5-HT-1D-beta 5-HT1B Serotonin 1D beta receptor HTR1D2 5-HT1B serotonin receptor 5-HT1DB 5-HT1Dbeta 5-hydroxytryptamine (serotonin) receptor 1B, G protein-coupled serotonin receptor 1B S12 [ Show all ]
Disease	Chronic schizophrenics Major depressive disorder Migraine headaches Mood disorder Psychotic disorders Anxiety disorder [ Show all ]
Length	390
Amino acid sequence	MEEPGAQCAPPPPAGSETWVPQANLSSAPSQNCSAKDYIYQDSISLPWKVLLVMLLALITLATTLSNAFVIATVYRTRKLHTPANYLIASLAVTDLLVSILVMPISTMYTVTGRWTLGQVVCDFWLSSDITCCTASILHLCVIALDRYWAITDAVEYSAKRTPKRAAVMIALVWVFSISISLPPFFWRQAKAEEEVSECVVNTDHILYTVYSTVGAFYFPTLLLIALYGRIYVEARSRILKQTPNRTGKRLTRAQLITDSPGSTSSVTSINSRVPDVPSESGSPVYVNQVKVRVSDALLEKKKLMAARERKATKTLGIILGAFIVCWLPFFIISLVMPICKDACWFHLAIFDFFTWLGYLNSLINPIIYTMSNEDFKQAFHKLIRFKCTS
UniProt	P28222
Protein Data Bank	4iar, 6g79, 5v54
GPCR-HGmod model	P28222
3D structure model	This structure is from PDB ID 4iar.
BioLiP	BL0239857, BL0403524,BL0403525, BL0417722
Therapeutic Target Database	T07806
ChEMBL	CHEMBL1898
IUPHAR	2
DrugBank	BE0000797

Ligand

Name	ondansetron
Molecular formula	C18H19N3O
IUPAC name	9-methyl-3-[(2-methylimidazol-1-yl)methyl]-2,3-dihydro-1H-carbazol-4-one
Molecular weight	293.37
Hydrogen bond acceptor	2
Hydrogen bond donor	0
XlogP	2.3
Synonyms	PMS-ondansetron BR-29654 s1996 CAS_68647 SPBio_002938 D00456 Tox21_113048 DTXSID8023393 1,2,3,4-Tetrahydro-9-methyl-3-(2-methyl-1H-imidazol-1-ylmethyl)carbazol-4-one GR38032 103639-04-9 I06-0687 9-methyl-3-((2-methyl-1H-imidazol-1-yl)methyl)-1,2,3,9-tetrahydro-4H-carbazol-4-one LS-51878 99614-01-4 (mono-hydrochloride) NCI60_022780 AB2000413 Zofran ODT ONDANSETRON HCl Apo-ondansetron BC220610 Prestwick2_001058 BRN 3622981 SBB066158 ST077669 DB00904 GR 38032 1,2,3,9-tetrahydro-9-methyl-3-[(2-methyl-1H-imidazol-1-yl)methyl]-4H- carbazol-4-one HMS2090H16 116002-70-1 KB-308401 9-methyl-3-[(2-methyl-1H-imidazol-1-yl)methyl]-1,2,3,9-tetrahydro-4H-carbazol-4-one MolPort-001-944-253 AB00373674 VA11441 Odansetron [common misspelling of ondansetron] ACN-049703 Zudan Ondansetron [USP:INN:BAN] BDBM85330 Ratio-ondansetron C18H19N3O SMR001307702 CS-2393 TimTec1_001750 DSSTox_GSID_23393 GR-38032F 1,2,3,9-tetrahydro-9-methyl-3-[(2-methyl-1H-imidazole-1 -yl)methyl]-4H-carbazol-4-one HSDB 8304 L000456 9-methyl-3-[(2-methylimidazolyl)methyl]-1,2,3,9-tetrahydro-4aH-carbazol-4-one NCGC00179341-04 AB00373674_18 Zofran (TN) Ondansetron (JAN/USP/INN) AKOS016340526 Oprea1_852372 Prestwick0_001058 BRD-A19736161-001-01-8 SAM002589958 CBDivE_008994 SR-01000763250 D0K7WK Tox21_113048_1 FELGMEQIXOGIFQ-UHFFFAOYSA-N 1,2,3,9,-Tetrahydro-9-methyl-3-[(2-methyl-1H-imidazol-1-yl)methyl]-4H-carbazol-4-one GR38032F 103639-04-9 (mono-hydrochloride dihydrate) I06-1329 9-Methyl-3-((2-methyl-1H-imidazol-1-yl)methyl)-2,3-dihydro-1H-carbazol-4(9H)-one MCULE-9438746800 99614-02-5 Novo-ondansetron AC-28927 Zofran ODT (TN) Ondansetron Injection BAS 00717177 BCP28911 Prestwick3_001058 BSPBio_001016 SC-07554 CHEMBL46 ST2412612 DESMETHYLONDANSETRON GR 38032X 1,2,3,9-tetrahydro-9-methyl-3-[(2-methyl-1H-imidazol-1-yl)methyl]-4H-carbazol-4-one HMS3259H08 39O049 KS-00000JSZ 9-methyl-3-[(2-methyl-1H-imidazol-1-yl)methyl]-2,3,4,9-tetrahydro-1H-carbazol-4-one NC00706 AB00373674-15 Z1741971217 ACT02589 Zuplenz Ondansetron, (+,-)-Isomer PHL-ondansetron BPBio1_001118 S-2116 CAS-99614-02-5 SN-307 CTK8G2184 TL8006071 DSSTox_RID_77011 (RS)-1,2,3,9-Tetrahydro-9-methyl-3-(2-methylimidazol-1-ylmethyl)carbazol-4-one GR-38032F/GR-38032 1,2,3,9-tetrahydro-9-methyl-3-[(2-methyl-1H-imidazole-1-yl)methyl]-4H-carbazol-4-one HY-B0002B 9-Methyl-3- (2-methyl-imidazol-1ylmethyl)-1,2,3,9-tetrahydro-carbazol-4-one LS-172305 99614-01-4 NCGC00179341-07 AB00373674_19 ZOFRAN IN PLASTIC CONTAINER ondansetron (Zofran) AN-6592 Prestwick1_001058 BRD-A19736161-003-03-0 Sandoz ondansetron CHEBI:7773 SR-01000763250-4 FT-0631004 1,2,3,9-Tetrahydro-9-methyl-3-((2-methyl-1H-imidazol-1-yl)methyl)-4H-carbazol-4-one GTPL2290 108303-49-7 I544 9-Methyl-3-(2-methyl-imidazol-1-ylmethyl)-1,2,3,9-tetrahydro-carbazol-4-one MLS006011928 AB0013753 NSC_68647 AC1L1IIM Zophren Ondansetron [USAN:INN:BAN] BBL010304 BCP9001025 QC-660 C07325 SCHEMBL4542 CPD001307702 STK370548 DSSTox_CID_3393 GR-38032 1,2,3,9-Tetrahydro-9-methyl-3-[(2-methyl-1H-imidazol-1yl)methyl]-4H-carbazol-4-one HMS3371E18 4H-Carbazol-4-one, 1,2,3,9-tetrahydro-9-methyl-3-((2-methyl-1H-imidazol-1-yl)methyl)- KS-5227 9-methyl-3-[(2-methylimidazol-1-yl)methyl]-2,3-dihydro-1H-carbazol-4-one NCGC00179341-02 AB00373674-17 Zofran Ondansetron (base and/or unspecified salts) AKOS000599484 Oprea1_435466 [ Show all ]
Inchi Key	FELGMEQIXOGIFQ-UHFFFAOYSA-N
Inchi ID	InChI=1S/C18H19N3O/c1-12-19-9-10-21(12)11-13-7-8-16-17(18(13)22)14-5-3-4-6-15(14)20(16)2/h3-6,9-10,13H,7-8,11H2,1-2H3
PubChem CID	4595
ChEMBL	CHEMBL46
IUPHAR	N/A
BindingDB	85330
DrugBank	DB00904
Structure SDF download
Lipinski's druglikeness	This ligand satisfies Lipinski's rule of five.

Experimental Data

Parameter	Value	Reference	Database source
	N/A	N/A	DrugBank

zhanglabzhanggroup.org | +65-6601-1241 | Computing 1, 13 Computing Drive, Singapore 117417